Varda Space Industries has partnered with United Therapeutics to develop improved lung disease treatments using microgravity manufacturing, following successful experiments including a more effective form of cancer drug Keytruda. The company's autonomous bioreactor capsules represent a significant step toward commercial pharmaceutical production in space, though historically such research has been limited by NASA's constraints and costs. This collaboration signals growing pharmaceutical industry interest in space-based drug manufacturing.
Background
NASA has long enabled microgravity drug research, with notable successes like improving the cancer drug Keytruda's formulation. Private companies are now advancing this field with dedicated space manufacturing platforms.
- Source
- Ars Technica
- Published
- May 13, 2026 at 06:00 PM
- Score
- 7.0 / 10